- Voya Financial‘s adjusted operating EPS for Q4 is $1.40, compared to $1.63 year-over-year (y/y).
- The company’s adjusted operating EPS has beaten the market estimate of 71 cents.
- After-tax adjusted operating earnings reached $138 million, significantly surpassing the estimate of $84.6 million.
- Higher loss ratios in Health Solutions impacted results, particularly in the Stop Loss business.
- To address these issues, Voya Financial has implemented significant rate increases and improved underwriting risk selection.
- The stock received analyst ratings of 7 buys and 7 holds, with no sell recommendations.
“`
A look at Voya Financial Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 3 | |
| Growth | 3 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, Voya Financial seems to have a promising long-term outlook. With a strong Value score of 4, the company is perceived to offer good value for investors. Additionally, Voya Financial receives moderate scores across other key factors such as Dividend, Growth, Resilience, and Momentum, indicating a balanced overall performance.
Voya Financial, Inc., known for its focus on retirement, investment, and insurance services in the United States, appears well-positioned for future growth and stability. The company’s range of products and services cater to both individual and institutional customers, emphasizing asset accumulation, protection, and distribution. Although some areas may have room for improvement, Voya Financial‘s solid Value score implies a potentially attractive investment opportunity for those seeking value-oriented investments in the financial sector.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
